行业动态
garymarcus.substack.com ·
@Gary Marcus
联合国安理会首次 AI 简报会:Bengio、Altman、Amodei 同场发言
Gary Marcus 撰文记录联合国安理会 AI 简报会,Yoshua Bengio、Sam Altman、Dario Amodei 与 Hugging Face CEO Clement Delangue 先后发言,并全文转载 Bengio 讲稿。各方在飞行前安全测试、透明度审计、责任归属、全球对话与立即行动上趋于一致。Marcus 同时批评 Altman 与 Amodei 的自我宣传,尤其指出 Amodei 将当日公布的酶发现过早类比 CRISPR,而该成果仅找到序列、可能表达出蛋白,尚未完成有意义的功能表征。
AI推荐理由 Gary Marcus 记录了联合国安理会 AI 简报会,Bengio、Altman、Amodei、Delangue 同场发言,并全文转载 Bengio 讲稿,同时给出对 Amodei 夸大酶发现、过早类比 CRISPR 的具体批评,含明确引用与判断依据,对 AI 安全治理讨论有实质参考价值;但属个人评论文章,观点立场需自行甄别。
78
正文
This afternoon at the UN Security Council, Yoshua Bengio, Sam Altman, Dario Amodei, and Hugging Face CEO and Cofounder Clement Delangue gave back-to-back speeches. I absolutely loved Bengio’s, agreeing with virtually every well-crafted word, and, with his permission, am reprinting his remarks in full, below. The more surprising thing is that I agreed with almost all of what the other three said as well (and most of what followed, as many other speakers from around the world gave their own remarks).1 Pretty much everyone converged on exactly the same things I keep harping on: The need for preflight safety testing. The need for transparency auditing. The need for liability. The need for global dialogue and international cooperation. The need for immediate action. At this point, with leading scientists (like Bengio) and major CEOs all reaching consensus, there is no excuse not to start implementing them. Share Here are Yoshua Bengio’s beautiful and important remarks. Humanity will regret it if we do not take heed. The full session (which starts several minutes into the recording) can be viewed here. A transcript will be available at the same location. Subscribe now 1 The only real false note came from some self-congratulatory hype in the speeches of Altman and Amodei, especially Amodei’s. Amodei in particular overhyped a discovery announced early today, in enzymes, which Amodei prematurely tried to liken to the truly revolutionary gene editing system CRISPR. In reality, as , put it “They found the sequence, probably expressed a protein, but haven’t done any meaningful functional characterization… It’s not bad, it’s just very premature to compare to CRISPR.”